Shanghai RAAS Blood Products Co., Ltd. (SHANGHAI RAAS BLOOD PRODUCTS CO) aktie
002252.SZ
Fördröjd 15 minSHANGHAI RAAS BLOOD PRODUCTS CO
Market Cap
$33,920,102,400
Om Shanghai RAAS Blood Products Co., Ltd. (SHANGHAI RAAS BLOOD PRODUCTS CO) aktie
Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinogen; FIBINGLURAAS, a fibrin sealant for humans; and THROMBIRAAS, a human thrombin product. It also provides specific immune, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin, hepatitis B human immunoglobulin, and other blood products. The company exports its products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is headquartered in Shanghai, China.
Företagsinformation
201401 Shanghai, China
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.